Effective adjunctive use of tandospirone with perospirone for enhancing verbal memory and quality of life in schizophrenia.
Sumiyoshi
Tomiki
T
Higuchi
Yuko
Y
Matsui
Mie
M
Arai
Hirofumi
H
Takamiya
Chieko
C
Meltzer
Herbert Y
HY
Kurachi
Masayoshi
M
D000328:Adult; D014151:Anti-Anxiety Agents / Q000494:pharmacology* / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D007211:Indoles / Q000494:pharmacology* / Q000627:therapeutic use; D054833:Isoindoles; D008297:Male; D008568:Memory / Q000187:drug effects*; D010879:Piperazines / Q000494:pharmacology* / Q000627:therapeutic use; D011743:Pyrimidines / Q000494:pharmacology* / Q000627:therapeutic use; D011788:Quality of Life; D012559:Schizophrenia / Q000188:drug therapy / Q000503:physiopathology; D012565:Schizophrenic Psychology; D013844:Thiazoles / Q000494:pharmacology* / Q000627:therapeutic use; D014705:Verbal Behavior / Q000187:drug effects*
D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents; D007211:Indoles; D054833:Isoindoles; D010879:Piperazines; D011743:Pyrimidines; D013844:Thiazoles; C055267:tandospirone; C065533:perospirone